This is in accordance with other reports supporting that TMB does not significantly correlate with cellular or molecular immune phenotypes in HNSCC, indicating that the presence of neoantigens might be a necessary but not a sufficient factor to mount an effective anti-tumor immunity in HNSCC patients [54,55,66].In contrast, the T cell-inflamed GEP was significantly correlated with PD-L1 in HNSCC, similar to the pan-cancer cohort, consistent with the known regulation of PD-L1 gene expression by IFN-γ from activated T cells [95]. The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.